Heart Disease Clinical Trials in Iowa

48 recruiting studies across 9 cities

All Trials in Iowa

Phase
Trial Phase Location
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac ToxicityPhase 3Clive
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes MedicationsPhase 3Council Bluffs
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and ObesityPhase 3Davenport
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACSPhase 3Davenport
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE—Des Moines
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.N/ADes Moines
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)—Iowa City
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter SystemN/AIowa City
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious InfectionsPhase 3Iowa City
ATrial Tachycardia PAcing Therapy in Congenital Heart—Iowa City
Acceptance and Commitment Therapy for Patients Undergoing Coronary Artery Bypass Graft SurgeryN/AIowa City
Adenosine vs Diltiazem for Treatment of SVT in the EDPhase 4Iowa City
Anticoagulation in ICH Survivors for Stroke Prevention and RecoveryPhase 3Iowa City
Assessment of CCM in HF With Higher Ejection FractionN/AIowa City
BOdygUardian MOnitoriNg for ReCurrencE of AF—Iowa City
Cell Free DNA in Cardiac SarcoidosisN/AIowa City
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in WomenN/AIowa City
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical TrialN/AIowa City
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval StudyN/AIowa City
Impact of Bromocriptine on Clinical Outcomes for Peripartum CardiomyopathyPhase 4Iowa City
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomesPhase 4Iowa City
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease—Iowa City
Optimal Ventilation for Cardiac ArrestN/AIowa City
PERceptions of Diltiazem Versus ADEnosine for Treatment of Supraventricular Tachycardia in the Emergency Department—Iowa City
Paced Heart Rate Acceleration for Cardiac ConditioningN/AIowa City
Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program—Iowa City
Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)N/AIowa City
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)—Iowa City
Physiology-directed Epinephrine Dosing in Pediatric Cardiac Arrest—Iowa City
Product Surveillance Registry—Iowa City
Quality of Pediatric Resuscitation in a Multicenter Collaborative—Iowa City
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias—Iowa City
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart FailureN/AIowa City
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial FibrillationPhase 3Iowa City
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart FailureN/AIowa City
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)Phase 2/3Sioux City
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEFPhase 3Waterloo
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney FunctionPhase 3Waterloo
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular EventsN/AWest Des Moines
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the HeartPhase 3West Des Moines
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart FailurePhase 3West Des Moines
Encore PFO Closure Device - The PerFOrm TrialN/AWest Des Moines
Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial FibrillationN/AWest Des Moines
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular InterventionPhase 4West Des Moines
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular EventsPhase 3West Des Moines
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products—West Des Moines
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)Phase 3West Des Moines
The Fourth Left Atrial Appendage Occlusion StudyN/AWest Des Moines

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.